Camena Bioscience: Nicola Thompson
UK synthetic biology firm Camena Bioscience has appointed Nicola Thompson as chair of its board of directors. Previously, she was the founding CEO of Amphista Therapeutics, and before that, chair of the board of Nanna Therapeutics. She also held senior leadership roles at Roche. Thompson has a PhD in cell biology from University College London.